BC
GSK icon

Broadwater Capital’s GSK GSK Stock Holding History

Broadwater Capital’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.7K Hold
300
– – 0.01% 139
2026
Q1 		$14.7K Hold
300
– – 0.01% 142
2025
Q4 		$14.7K Hold
300
– – 0.01% 142
2025
Q3 		$12.9K Sell
300
-11,220
-97% -$438K 0.01% 153
2025
Q2 		$11.5M Buy
11,520
+11,220
+3,740% +$429K 0.01% 157
2025
Q1 		$11.6K Hold
300
– – 0.01% 157
2024
Q4 		$10.1K Hold
300
– – 0.01% 169
2024
Q3 		$12.3K Hold
300
– – 0.01% 165
2024
Q2 		$11.6K Hold
300
– – 0.01% 167
2024
Q1 		$12.9K Hold
300
– – 0.01% 161
2023
Q4 		$11.1K Buy
+300
New +$10.8K 0.01% 166

Other funds holding GSK

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
MHI
Miller Howard Investments Kingston, New York $3.77B AUM 23.82% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return

Broadwater Capital's GSK Position: Q2 2026 in Review

Broadwater Capital held its GSK (GSK) position steady in Q2 2026 at 300 shares worth $15.7K. The position accounts for 0.01% of the portfolio, ranked #139.

Broadwater Capital first reported a position in GSK in Q4 2023 and has held it in 11 quarters since. The position peaked at $11.5M in Q2 2025. 551 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Broadwater Capital held 300 shares of GSK worth $15.7K as of Q2 2026.
  • Broadwater Capital left its GSK share count unchanged in Q2 2026.
  • GSK made up 0.01% of Broadwater Capital's portfolio in Q2 2026, its #139 holding.
  • Broadwater Capital first reported a position in GSK in Q4 2023 and has held it in 11 quarters since.
  • Broadwater Capital's GSK position peaked at $11.5M in Q2 2025.
  • 551 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Broadwater Capital's 13F filing for Q2 2026, filed 24 Jul 2026.